AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

Events

AGORA PRS Special Guest Seminar, Dr. Aerin Yang | September 29th

More information

Highlighted publication

Dendritic cells as programmable platforms for cancer immunotherapy.

Liu Y, Marcandalli E, Liu Y, (…), Bayerl F, Pittet MJ, De Palma M

Trends in immunology – 2026 Sep 16

News

Call for TANDEM projects | 2027

Highlight

AGORA Store is here!

Events

Inaugural Lecture of Prof. Etienne Meylan | September 28th

More information

Events

Oncology Grand Rounds, Prof. Cindy Neuzillet| October 2nd

More information

Events

EPFL Latsis Symposium 2026 | October 29-30

Register

Highlighted publication

Perioperative myeloid cell remodeling shapes CAR-T cell efficacy in glioblastoma

Pedard M, Castillo Cantero L, Ghasemi A, (…), Pittet MJ, Dutoit V, Migliorini D

Nature Communications – 2026 Jul 31

Highlighted publication

Who gets told what is impossible?

Joyce JA

Nature reviews. Cancer – 2026 Jul 27

Highlighted publication

Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer.

Beziaud L, Minasyan A, Chiang CL, (…), Tissot S, Dangaj-Laniti D, Kandalaft LE

iScience – 2026 Jun 30

Events

AGORA PRS Seminar | September 15

More information

Events

Swiss Myeloid League (SMyLe) monthly Seminar series | September 15th

More information

Past news

Latest publications

Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.

Macchia G, Morganti AG, Taylor A, (…), Herrera FG, Jereczek-Fossa BA, Guckenberger M

The Lancet. Oncology – 2026 Sep 28

Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency.

Tao R, Erkek-Ozhan S, Xu B, (…), Peng JC, Pfister SM, Northcott PA

Nature genetics – 2026 Sep 24

Revealing therapeutic single-cell transcriptomic signatures using a simple classifier.

Ma X, Seah YFS, Gfeller D, Merten CA

Cell reports methods – 2026 Sep 18

Dendritic cells as programmable platforms for cancer immunotherapy.

Liu Y, Marcandalli E, Liu Y, (…), Bayerl F, Pittet MJ, De Palma M

Trends in immunology – 2026 Sep 16

An eicosanoid-enriched follicular microenvironment shapes germinal centre immune dynamics in antiretroviral-treated PLWH.

Georgakis S, Lindsay H, Orfanakis M, (…), Ribeiro SP, Gottardo R, Petrovas C

bioRxiv : the preprint server for biology – 2026 Sep 14